Modern biomarker
and translational research as well as personalized
health care studies rely heavily on powerful omics’ technologies,
including metabolomics and lipidomics. However, to translate metabolomics
and lipidomics discoveries into a high-throughput clinical setting,
standardization is of utmost importance. Here, we compared and benchmarked
a quantitative lipidomics platform. The employed Lipidyzer platform
is based on lipid class separation by means of differential mobility
spectrometry with subsequent multiple reaction monitoring. Quantitation
is achieved by the use of 54 deuterated internal standards and an
automated informatics approach. We investigated the platform performance
across nine laboratories using NIST SRM 1950–Metabolites in
Frozen Human Plasma, and three NIST Candidate Reference Materials
8231–Frozen Human Plasma Suite for Metabolomics (high triglyceride,
diabetic, and African-American plasma). In addition, we comparatively
analyzed 59 plasma samples from individuals with familial hypercholesterolemia
from a clinical cohort study. We provide evidence that the more practical
methyl-tert-butyl ether extraction outperforms the classic Bligh and
Dyer approach and compare our results with two previously published
ring trials. In summary, we present standardized lipidomics protocols,
allowing for the highly reproducible analysis of several hundred human
plasma lipids, and present detailed molecular information for potentially
disease relevant and ethnicity-related materials.